Europe Vaccine Adjuvant Market by Type (Aluminium Salts, Tensoactive Adjuvants, Adjuvant Emulsions, Bacteria derived Adjuvants, Liposome Adjuvants and Carbohydrate Adjuvants) by Route of Administration (Oral, Intradermal, Subcutaneous, Intranasal and Intramuscular), by Mechanism of Action (Immuno Stimulants, Carriers and Vehicle Adjuvants) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Europe Vaccine Adjuvant Market by Type (Aluminium Salts, Tensoactive Adjuvants, Adjuvant Emulsions, Bacteria derived Adjuvants, Liposome Adjuvants and Carbohydrate Adjuvants) by Route of Administration (Oral, Intradermal, Subcutaneous, Intranasal and Intramuscular), by Mechanism of Action (Immuno Stimulants, Carriers and Vehicle Adjuvants) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 679 | Pages: 143 | October 2016 | Region: Europe


The Europe Vaccine Adjuvant Market was worth $113.28 million in 2016 and estimated to be growing at a CAGR of 10.55%, to reach $187.05 million by 2021. Europe is the second largest vaccine adjuvant market globally.

A Vaccine adjuvant is a component of a vaccine that supports to create a stronger immune response in the patient’s body.  Specifically, adjuvants help vaccines work better. Some vaccines prepared from deteriorated or dead germs comprise of naturally occurring adjuvants and support the body to create a strong protective immune response. Most vaccines invented today comprise of just minor components of germs, such as their proteins, rather than the entire virus or bacteria.

The market for Vaccine Adjuvants is growing quickly. The factors that affect the growth of Vaccine Adjuvants market are extending government schemes for vaccinations, mechanical innovations, Unmet Vaccine advertise necessities for specific diseases, increasing consumption of recombinant subunit and industrial immunizations are the driving components for this market. Lack of scientific awareness is hampering the market growth.

The Europe vaccine adjuvants market is segmented on the basis of type into Aluminium Salts, Tensoactive Adjuvants, Adjuvant emulsions, Bacteria derived Adjuvants, Liposome Adjuvants and Carbohydrate Adjuvants. Based on route of administration, the market is divided into oral, intradermal, subcutaneous, intranasal and intramuscular. The market is bifurcated on the basis of mechanism of action into active immuno stimulants, carriers and vehicle adjuvants. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016.    

Based on geography the market is analysed under various regions namely, Germany, Spain, Italy, France and U.K. Germany and U.K are expected to experience robust growth in the forecast period due to increasing awareness in the region.

The key players in the vaccine adjuvants market include MPV Technologies (U.S.), Avanti Polar Lipids, Novavax Inc. (U.S.), Inc. (U.S.), Brenntag Biosector (Denmark), SEPPIC (France), Agenus, Inc. (U.S.), Invivogen (U.S.), SPI Pharma, Inc. (U.S.), CSL Limited (Australia), and OZ Biosciences (France).

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Aluminium Salts    

                                5.1.2 Tensoactive Adjuvants      

                                5.1.3 Adjuvant Emulsions            

                                5.1.4 Bacteria derived Adjuvants              

                                5.1.5 Liposome Adjuvants           

                                5.1.6 Carbohydrate Adjuvants   

                5.2 By Route of Administration                 

                                5.2.1 Oral            

                                5.2.2 Intradermal            

                                5.2.3 Subcutaneous       

                                5.2.4 Intranasal                

                                5.2.5 Intramuscular        

                5.3 By Mechanism of Action                       

                                5.3.1 Immuno Stimulants             

                                5.3.2 Carriers     

                                5.3.3 Vehicle Adjuvants

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 U.K 

                                6.3 Spain             

                                6.4 Germany     

                                6.5 Italy               

                                6.6 France          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 MPV Technologies                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Avanti Polar Lipids                   

                8.3 Novavax Inc.                              

                8.4 Brenntag Biosector                 

                8.5 SEPPIC                          

                8.6 Agenus, Inc.                               

                8.7 Invivogen                    

                8.8 SPI Pharma Inc.                         

                8.9 CSL Limited                 

                8.10 OZ Biosciences                        

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Vaccine Adjuvant Market By Region, From 2016-2021 (USD Million)
  2. Europe Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  3. Europe Aluminium Salts Market By Region, From 2016-2021 (USD Million)
  4. Europe Tensoactive Adjuvants Market By Region, From 2016-2021 (USD Million)
  5. Europe Adjuvant Emulsions Market By Region, From 2016-2021 (USD Million)
  6. Europe Bacteria derived Adjuvants Market By Region, From 2016-2021 (USD Million)
  7. Europe Liposome Adjuvants Market By Region, From 2016-2021 (USD Million)
  8. Europe Carbohydrate Adjuvants Market By Region, From 2016-2021 (USD Million)
  9. Europe Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  10. Europe Oral Market By Region, From 2016-2021 (USD Million)
  11. Europe Intradermal Market By Region, From 2016-2021 (USD Million)
  12. Europe Subcutaneous Market By Region, From 2016-2021 (USD Million)
  13. Europe Intranasal Market By Region, From 2016-2021 (USD Million)
  14. Europe Intramuscular Market By Region, From 2016-2021 (USD Million)
  15. Europe Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
  16. Europe Immuno Stimulants Market By Region, From 2016-2021 (USD Million)
  17. Europe Carriers Market By Region, From 2016-2021 (USD Million)
  18. Europe Vehicle Adjuvants Market By Region, From 2016-2021 (USD Million)
  19. U.K Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  20. U.K Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  21. U.K Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
  22. Spain Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  23. Spain Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  24. Spain Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
  25. Germany Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  26. Germany Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  27. Germany Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
  28. Italy Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  29. Italy Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  30. Italy Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
  31. France Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  32. France Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  33. France Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
North America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncolog...
Middle East And Africa High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application...
Latin America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncolog...
Europe High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glau...
Asia Pacific High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology...
High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glaucoma, H...
North America Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screen...
Middle East And Africa Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pestici...
Latin America Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screen...
Europe Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screening, Ge...
Asia Pacific Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screeni...
Global Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screening, Ge...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.